SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A99F15C14D31888FF5A139C3E00E2356461972CB0C3694DFA60E45A9EC1487C1237813ECF9E379401C8FAEA2E240DA21>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A99F15C14D31888FF5A139C3E00E2356461972CB0C3694DFA60E45A9EC1487C1237813ECF9E379401C8FAEA2E240DA21
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A99F15C14D31888FF5A139C3E00E2356461972CB0C3694DFA60E45A9EC1487C1237813ECF9E379401C8FAEA2E240DA21
http://www.w3.org/2000/01/rdf-schema#comment
"we propose that WASF1 status defines a subtype of androgen deprivation therapy -resistant prostate cancer patients"
xsd:string
http://purl.uniprot.org/uniprot/#_241D841327DBF32AD8660F1E1BAE35163F38BB8D2E199E20312ED76F497B1A23D756A5A0AB631FEB785CA49A48A13225
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A99F15C14D31888FF5A139C3E00E2356461972CB0C3694DFA60E45A9EC1487C1237813ECF9E379401C8FAEA2E240DA21
http://purl.uniprot.org/uniprot/Q92558
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A99F15C14D31888FF5A139C3E00E2356461972CB0C3694DFA60E45A9EC1487C1237813ECF9E379401C8FAEA2E240DA21
http://purl.uniprot.org/uniprot/#_Q92558-mappedCitation-25906751
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A99F15C14D31888FF5A139C3E00E2356461972CB0C3694DFA60E45A9EC1487C1237813ECF9E379401C8FAEA2E240DA21